Yilun Deng

737 total citations
29 papers, 417 citations indexed

About

Yilun Deng is a scholar working on Immunology, Oncology and Physiology. According to data from OpenAlex, Yilun Deng has authored 29 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Oncology and 6 papers in Physiology. Recurrent topics in Yilun Deng's work include Cancer Immunotherapy and Biomarkers (10 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (8 papers). Yilun Deng is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (8 papers). Yilun Deng collaborates with scholars based in United States, China and Switzerland. Yilun Deng's co-authors include Patricia L. M. Dahia, Subramanya Srikantan, Yuejuan Qin, Ricardo C.T. Aguiar, Álvaro Padrón, Tyler J. Curiel, Harshita B. Gupta, Maria Adelaide A. Pereira, S. P. A. Toledo and Qun Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Yilun Deng

27 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yilun Deng United States 11 135 131 99 85 83 29 417
Tian Wu China 11 88 0.7× 92 0.7× 160 1.6× 116 1.4× 90 1.1× 19 506
Kirsty R. Greenow United Kingdom 9 100 0.7× 74 0.6× 55 0.6× 185 2.2× 55 0.7× 13 383
Caroline Ward United Kingdom 11 121 0.9× 67 0.5× 67 0.7× 76 0.9× 24 0.3× 20 404
Kaida Ji China 11 86 0.6× 87 0.7× 59 0.6× 170 2.0× 60 0.7× 15 429
Zhengju Fu China 10 77 0.6× 63 0.5× 78 0.8× 158 1.9× 23 0.3× 14 414
Valerie I. Elmalem United States 7 205 1.5× 61 0.5× 89 0.9× 62 0.7× 87 1.0× 12 402
Jun‐Long Song China 13 158 1.2× 143 1.1× 70 0.7× 90 1.1× 39 0.5× 30 432
Elisabetta L. Romeo Italy 13 63 0.5× 38 0.3× 141 1.4× 152 1.8× 46 0.6× 20 412
Daniela Liberati Italy 12 238 1.8× 78 0.6× 163 1.6× 206 2.4× 73 0.9× 16 551
Luqian Zhao China 11 134 1.0× 186 1.4× 31 0.3× 209 2.5× 53 0.6× 14 573

Countries citing papers authored by Yilun Deng

Since Specialization
Citations

This map shows the geographic impact of Yilun Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yilun Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yilun Deng more than expected).

Fields of papers citing papers by Yilun Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yilun Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yilun Deng. The network helps show where Yilun Deng may publish in the future.

Co-authorship network of co-authors of Yilun Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Yilun Deng. A scholar is included among the top collaborators of Yilun Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yilun Deng. Yilun Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Padrón, Álvaro, Yilun Deng, Yiji Liao, et al.. (2023). Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects. Journal for ImmunoTherapy of Cancer. 11(2). e004871–e004871. 8 indexed citations
4.
Deng, Yilun, Simiao Wu, Junfeng Liu, et al.. (2022). The stress hyperglycemia ratio is associated with the development of cerebral edema and poor functional outcome in patients with acute cerebral infarction. Frontiers in Aging Neuroscience. 14. 936862–936862. 26 indexed citations
5.
Tao, Wendan, Junfeng Liu, Jie Li, et al.. (2022). Acute Cerebral Microinfarcts in Acute Ischemic Stroke: Imaging and Clinical Significance. Cerebrovascular Diseases. 51(6). 755–763. 3 indexed citations
6.
Zhang, Deyi, Harshita B. Gupta, Álvaro Padrón, et al.. (2021). Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy. Cancer Medicine. 10(6). 2137–2152. 34 indexed citations
7.
Deng, Yilun, et al.. (2021). Targeting Ovarian Cancer with IL-2 Cytokine/Antibody Complexes: A Summary and Recent Advances. PubMed. 3(6). 387–396. 1 indexed citations
8.
Deng, Yilun, Bi Zhao, Bing Wei, Shihong Zhang, & Ming Liu. (2021). Parotid carcinoma following chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids: a case report. BMC Neurology. 21(1). 110–110. 4 indexed citations
9.
Deng, Yilun, Deyi Zhang, Niannian Ji, et al.. (2021). CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation. Journal for ImmunoTherapy of Cancer. 9(4). e002051–e002051. 14 indexed citations
10.
Drerup, Justin, Yilun Deng, Álvaro Padrón, et al.. (2020). CD122-Selective IL2 Complexes Reduce Immunosuppression, Promote Treg Fragility, and Sensitize Tumor Response to PD-L1 Blockade. Cancer Research. 80(22). 5063–5075. 27 indexed citations
11.
Deng, Yilun, Afaf Saliba, Nelly Burnichon, et al.. (2020). Functional Characterization of TMEM127 Variants Reveals Novel Insights into Its Membrane Topology and Trafficking. The Journal of Clinical Endocrinology & Metabolism. 105(9). e3142–e3156. 7 indexed citations
12.
Li, Ziqing, Puyi Sheng, Chaohong Li, Gongsheng Yuan, & Yilun Deng. (2020). Osteoimmunology in Bone Regeneration. BioMed Research International. 2020(1). 6297356–6297356. 2 indexed citations
13.
Deng, Yilun, Yuejuan Qin, Subramanya Srikantan, et al.. (2018). The TMEM127 human tumor suppressor is a component of the mTORC1 lysosomal nutrient-sensing complex. Human Molecular Genetics. 27(10). 1794–1808. 15 indexed citations
14.
15.
Qin, Yuejuan, Yilun Deng, Christopher J. Ricketts, et al.. (2013). The tumor susceptibility gene TMEM127  is mutated in renal cell carcinomas and modulates endolysosomal function. Human Molecular Genetics. 23(9). 2428–2439. 40 indexed citations
16.
Zhang, Yonggang, Jingsheng Huang, Chao He, et al.. (2010). The I/D polymorphism of angiotensin-converting enzyme gene and asthma risk: a meta-analysis. Allergy. 66(2). 197–205. 38 indexed citations
17.
Deng, Yilun, et al.. (1992). A Soluble Protease Identified from Rat Kidney Degrades Endothelin-1 but Not Proendothelin-1. The Journal of Biochemistry. 112(1). 168–172. 12 indexed citations
18.
Deng, Yilun, et al.. (1992). Identification and Partial Purification of a Thiol Endothelin- Converting Enzyme from Porcine Aortic Endothelial Cells. The Journal of Biochemistry. 111(3). 346–351. 10 indexed citations
19.
Deng, Yilun. (1988). Genetics and development of the A(1) component of the phenoloxidase system of Drosophila melanogaster.. Deep Blue (University of Michigan). 2 indexed citations
20.
Li, X. J., et al.. (1979). Studies on fructose 1 6 di phosphatase in chloroplasts 1. isolation of chloroplast fructose 1 6 di phosphatase and comparison of some kinetic properties of the purified enzyme with that from freshly ruptured chloroplasts. Zhiwu xuebao. 21(3). 231–237. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tian Wu Breakdown of academic impact, for papers by Kirsty R. Greenow Breakdown of academic impact, for papers by Caroline Ward Breakdown of academic impact, for papers by Kaida Ji Breakdown of academic impact, for papers by Zhengju Fu Breakdown of academic impact, for papers by Valerie I. Elmalem Breakdown of academic impact, for papers by Jun‐Long Song Breakdown of academic impact, for papers by Elisabetta L. Romeo Breakdown of academic impact, for papers by Daniela Liberati Breakdown of academic impact, for papers by Luqian Zhao
Rankless by CCL
2026